Advertisement
LNC vs MET
Which Stock Would AI Choose? Lincoln National (LNC) vs. MetLife (MET) Stock Comparison
Key Takeaways
- Lincoln National (LNC) is a mid-cap U.S. life insurance and retirement carrier executing a multi-year capital and de-risking turnaround, while MetLife (MET) is a diversified, globally scaled insurer with steadier earnings breadth.
- MetLife has shown stronger recent momentum and relative performance, supported by double-digit adjusted earnings growth and consistent share buybacks, whereas Lincoln National's recovery is more execution-dependent.
- Lincoln National trades at a lower valuation and higher dividend yield, reflecting its legacy-block and variable annuity risks; MetLife commands a premium for its diversification and stability.
- Tickeron AI Verdict: MetLife (MET) is the ticker Tickeron's AI would currently favor, based on trend consistency, diversified catalysts, and more stable market positioning.
- Explore LNC Major News and LNC Today's Price Move, plus MET Major News and MET Today's Price Move, for additional real-time context on each name.
- For automated, data-driven trading ideas across thousands of tickers, explore Trending AI Robots.
Introduction
Investors comparing LNC and MET are weighing two very different plays within the same insurance sector. Lincoln National is a focused U.S. life insurance, annuity, and retirement specialist navigating a capital-repair story, while MetLife is a globally diversified insurer with operations spanning group benefits, retirement, Asia, Latin America, EMEA, and asset management. This comparison is most relevant for investors deciding between a higher-yielding turnaround candidate with greater execution risk and a larger, steadier franchise with broader geographic reach. Understanding each company's recent price behavior, growth drivers, and market positioning can help clarify which risk-reward profile better fits a given portfolio.
LNC Overview and Recent Performance
Lincoln National Corporation (LNC) is a U.S.-based life insurance, annuity, group protection, and retirement plan services provider. In recent quarters, the company has focused on repairing its balance sheet after a period of capital pressure, driven partly by its legacy life and variable annuity businesses. Management has prioritized de-risking over aggressive volume growth, shifting annuities toward spread-based products and reducing market sensitivity.
Recent market activity has been mixed. Lincoln National has restarted common share buybacks after a nearly four-year pause, closed a multi-billion-dollar reinsurance transaction to reduce legacy life reserves, and reported consecutive quarters of year-over-year adjusted operating income growth. However, its stock has lagged the broader industry over the year-to-date period, and shares have pulled back in recent weeks amid variable annuity outflows and concerns about group protection profitability normalizing. Its relatively high dividend yield reflects both income appeal and lingering skepticism about the turnaround's durability.
MET Overview and Recent Performance
MetLife, Inc. (MET) is one of the world's largest life insurers, with a diversified footprint across Group Benefits, Retirement and Income Solutions, Asia, Latin America, EMEA (Europe, the Middle East, and Africa), and MetLife Investment Management. This geographic and product diversification gives MetLife multiple earnings levers, reducing dependence on any single market or line of business.
Recent performance has been comparatively strong. MetLife has posted double-digit adjusted earnings per share (EPS) growth, with notable strength in Group Benefits and its international segments, and it has maintained an active share repurchase program, including a new multi-billion-dollar authorization. The stock has advanced meaningfully year to date, outperforming its industry and sector, and continues to draw largely constructive analyst ratings with steadily rising price targets. This momentum reflects improving underwriting, favorable investment income, and successful execution of its "New Frontier" expense and growth strategy.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI trading bots drawn from a much larger universe of hundreds of automated strategies. These bots collectively trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance history, and set of covered securities. Only the bots best suited to current market conditions earn a place in this featured section, making it a useful starting point for traders who want to filter through the noise and focus on strategies that are performing well right now. If you are looking to move beyond manual analysis of names like LNC and MET, exploring Trending AI Robots can help you discover automated approaches aligned with the current market environment.
Head-to-Head Comparison
These two insurers differ most sharply in scale, diversification, and risk profile. MetLife operates a global, multi-segment business with more than $700 billion in assets, giving it resilience across regions and product lines. Lincoln National is a domestically focused mid-cap whose earnings are more concentrated in U.S. life insurance, annuities, and group protection, making it more sensitive to domestic claims trends and equity-market fluctuations.
Growth drivers also diverge. MetLife's momentum stems from favorable underwriting, international volume growth, and disciplined capital returns, while Lincoln National's story centers on balance-sheet repair, legacy-block reinsurance, and a gradual shift toward less capital-intensive products. On risk, Lincoln National carries elevated exposure to variable annuity outflows and execution risk around its de-risking initiatives, whereas MetLife's primary risks include spread compression in retirement products and valuation premium after a strong run.
Market sentiment reflects this contrast: MetLife's relative performance and analyst consensus are notably stronger, while Lincoln National trades at a lower multiple and higher yield, a classic value-versus-quality trade-off within the sector.
Tickeron AI Verdict
Based on observable factors such as trend consistency, earnings momentum, catalyst quality, and relative positioning, Tickeron's AI would currently favor MetLife (MET) over Lincoln National (LNC). MetLife exhibits a steadier upward trend, diversified earnings drivers, and ongoing shareholder returns, which tend to signal stronger and more durable relative positioning. Lincoln National offers a potentially attractive value and yield proposition, but its trajectory remains more dependent on successful execution of its restructuring and de-risking plans. In probabilistic terms, MetLife currently presents the more consistent risk-adjusted setup, though Lincoln National remains a legitimate consideration for investors seeking higher income and a recovery-oriented profile.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LNC is a Buy and MET is a Hold.
LNC's RSI Oscillator ascending out of oversold territory
The RSI Indicator for LNC moved out of oversold territory on October 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 22 of the 26 cases the stock moved higher. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on LNC as a result. In 72 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for LNC just turned positive on October 21, 2026. Looking at past instances where LNC's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
LNC moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where LNC advanced for three days, in 237 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LNC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for LNC entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.769) is normal, around the industry mean (1.339). P/E Ratio (3.435) is within average values for comparable stocks, (19.974). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (0.463). Dividend Yield (0.043) settles around the average of (0.047) among similar stocks. P/S Ratio (0.427) is also within normal values, averaging (1.303).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. LNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
MET sees MACD Histogram crosses below signal line
MET saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 27, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In 32 of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 60%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 25 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 68 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on MET as a result. In 47 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +2.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where MET advanced for three days, in 224 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 153 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 28 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.338) is slightly higher than the industry average of (1.339). P/E Ratio (19.190) is within average values for comparable stocks, (19.974). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.023) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
LNC | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 91 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 21 | |
SMR RATING 1..100 | 97 | 99 | |
PRICE GROWTH RATING 1..100 | 50 | 28 | |
P/E GROWTH RATING 1..100 | 90 | 12 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LNC's Valuation (19) in the Life Or Health Insurance industry is somewhat better than the same rating for MET (56). This means that LNC’s stock grew somewhat faster than MET’s over the last 12 months.
MET's Profit vs Risk Rating (21) in the Life Or Health Insurance industry is significantly better than the same rating for LNC (100). This means that MET’s stock grew significantly faster than LNC’s over the last 12 months.
LNC's SMR Rating (97) in the Life Or Health Insurance industry is in the same range as MET (99). This means that LNC’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (28) in the Life Or Health Insurance industry is in the same range as LNC (50). This means that MET’s stock grew similarly to LNC’s over the last 12 months.
MET's P/E Growth Rating (12) in the Life Or Health Insurance industry is significantly better than the same rating for LNC (90). This means that MET’s stock grew significantly faster than LNC’s over the last 12 months.
| LNC | MET | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 53% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 76% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 71% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 54% |
| Advances ODDS (%) | 6 days ago 72% | 13 days ago 65% |
| Declines ODDS (%) | 16 days ago 71% | 7 days ago 51% |
| BollingerBands ODDS (%) | N/A | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LNC’s FA Score shows that 1 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s).
- LNC’s FA Score: 1 green, 4 red.
- MET’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LNC’s TA Score shows that 5 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).
- LNC’s TA Score: 5 bullish, 3 bearish.
- MET’s TA Score: 5 bullish, 5 bearish.
Price Growth
LNC (@Life/Health Insurance) experienced а +3.63% price change this week, while MET (@Life/Health Insurance) price change was +0.90% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.19%. For the same industry, the average monthly price growth was -0.17%, and the average quarterly price growth was -2.78%.
Reported Earning Dates
LNC is expected to report earnings on Nov 05, 2026.
MET is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Life/Health Insurance (+1.19% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
Advertisement
LNC and
Correlation & Price change
A.I.dvisor indicates that over the last year, LNC has been closely correlated with MET. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LNC jumps, then MET could also see price increases.
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDXU | 69.04 | 4.70 | +7.30% |
| MicroSectors Gold Miners 3X Leveraged ETN (GDXU) | |||
| ETU | 5.47 | 0.08 | +1.48% |
| T-Rex 2X Long Ether Daily Target ETF (ETU) | |||
| INCO | 58.69 | 0.41 | +0.70% |
| Columbia India Consumer ETF (INCO) | |||
| BSTP | 39.71 | -0.18 | -0.46% |
| Innovator Buffer Step-Up Strategy ETF (BSTP) | |||
| IWO | 348.80 | -2.95 | -0.84% |
| iShares Russell 2000 Growth ETF (IWO) | |||